A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/663 (2006.01) A61K 9/19 (2006.01) A61K 31/662 (2006.01) A61K 47/12 (2006.01) A61P 19/00 (2006.01)
Patent
CA 2409930
A method of intravenously administering a bisphosphonate to a patient in need of bisphosphonate treatment comprising intravenously administering 4 mg of 2- (imidazol-1yl)-1-hydroxyethane-1,1-diphosphonic acid (soledronic acid) or a pharmaceutically acceptable salt hereof over a period of 15 minutes to a patient in need of said treatment.
L'invention porte sur un procédé d'administration par voie intraveineuse d'un bisphosphonate à un patient nécessitant un traitement au bisphosphonate. Ce procédé consiste à administrer par voie intraveineuse 4 mg d'acide 2-(imidazol-1yl)-1-hydroxyéthane-1,1-diphosphonique (acide solédronique) ou un sel acceptable d'un point de vue pharmaceutique de celui-ci sur une durée de 15 minutes.
Galli Bruno
Schran Horst
Seaman John J.
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Use of zoledronate for the manufacture of a medicament for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of zoledronate for the manufacture of a medicament for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of zoledronate for the manufacture of a medicament for... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2062389